These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Microalbuminuria is a predictor of adverse pregnancy outcomes including preeclampsia. Jayaballa M, Sood S, Alahakoon I, Padmanabhan S, Cheung NW, Lee V. Pregnancy Hypertens; 2015 Oct; 5(4):303-7. PubMed ID: 26597745 [Abstract] [Full Text] [Related]
3. Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography. Baweja S, Kent A, Masterson R, Roberts S, McMahon LP. BJOG; 2011 Aug; 118(9):1126-32. PubMed ID: 21481153 [Abstract] [Full Text] [Related]
4. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Waugh J, Hooper R, Lamb E, Robson S, Shennan A, Milne F, Price C, Thangaratinam S, Berdunov V, Bingham J. Health Technol Assess; 2017 Oct; 21(61):1-90. PubMed ID: 29064366 [Abstract] [Full Text] [Related]
7. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Kelly CB, Hookham MB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Menard MK, Aston CE, Lyons TJ. Diabetes Care; 2018 Jan; 41(1):120-127. PubMed ID: 29122892 [Abstract] [Full Text] [Related]
8. Should the spot albumin-to-creatinine ratio replace the spot protein-to-creatinine ratio as the primary screening tool for proteinuria in pregnancy? Cade TJ, de Crespigny PC, Nguyen T, Cade JR, Umstad MP. Pregnancy Hypertens; 2015 Oct; 5(4):298-302. PubMed ID: 26597744 [Abstract] [Full Text] [Related]
9. Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation. Lauszus FF, Rasmussen OW, Lousen T, Klebe TM, Klebe JG. Acta Obstet Gynecol Scand; 2001 Dec; 80(12):1096-103. PubMed ID: 11846705 [Abstract] [Full Text] [Related]
15. PIERS proteinuria: relationship with adverse maternal and perinatal outcome. Payne B, Magee LA, Côté AM, Hutcheon JA, Li J, Kyle PM, Menzies JM, Peter Moore M, Parker C, Pullar B, von Dadelszen P, Walters BN, PIERS Study Group (Appendix), von Dadelszen P, Magee LA, Douglas MJ, Walley KR, Russell JA, Lee SK, Gruslin A, Smith GN, Côté AM, Moutquin JM, Brown MA, Davis G, Walters BN, Sass N, Duan T, Zhou J, Mahajan S, Noovao A, McCowan LA, Kyle P, Moore MP, Bhutta SZ, Bhutta ZA, Hall, Steyn DW, Broughton Pipkin F, Loughna P, Robson S, de Swiet M, Walker JJ, Grobman WA, Lindheimer MD, Roberts JM, Mark Ansermino J, Benton S, Cundiff G, Hugo D, Joseph KS, Lalji S, Li J, Lott P, Ouellet AB, Shaw D, Keith Still D, Tawagi G, Wagner B, Biryabarema C, Mirembe F, Nakimuli A, Tsigas E, Merialdi M, Widmer M. J Obstet Gynaecol Can; 2011 Jun; 33(6):588-597. PubMed ID: 21846448 [Abstract] [Full Text] [Related]
17. Urine protein-to-creatinine ratio: a point of care for the diagnosis of preeclampsia. Salmon L, Mastrolia SA, Hamou B, Wilkof-Segev R, Beer-Weisel R, Klaitman V, Besser L, Erez O. Minerva Ginecol; 2018 Jun; 70(3):246-253. PubMed ID: 28994561 [Abstract] [Full Text] [Related]
18. Increased urinary orosomucoid excretion predicts preeclampsia in pregnant women with pregestational type 1 diabetes. Christiansen MS, Hesse D, Ekbom P, Hesse U, Damm P, Hommel E, Feldt-Rasmussen B, Mathiesen E. Diabetes Res Clin Pract; 2010 Jul; 89(1):16-21. PubMed ID: 20392509 [Abstract] [Full Text] [Related]